CB2 drug
Evidence from:
primary |
all sources
Related entities (8)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| 2-AG | interacts_with | CB2 | — | 1 |
| AEA | interacts_with | CB2 | — | 1 |
| cannabis use | targets | CB2 | — | 1 |
| CB2 | associated_with | CB1 receptor | — | 1 |
| CB2 | regulates | immune function | — | 1 |
| CB2 | regulates | inflammatory response | — | 1 |
| endocannabinoid system | interacts_with | CB2 | — | 1 |
| THC | targets | CB2 | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
- Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice. (2016)
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? (2014)
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cb2 receptor | drug | 8 | 18 |
| cb2 | drug | 5 | 9 |
| cannabinoid receptor 2 | drug | 1 | 1 |
| cnr2 | drug | — | — |